Clinical Trial Update: Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of lenalidomide and rituximab in chronic lymphocytic leukemia/small lymphocytic lymphoma is currently active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Revlimid (lenalidomide)
• Rituxan (rituximab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING